|
⚲
|
| Keyboard |
| Progyny Inc | |
|---|---|
| Ticker | PGNY |
| CIK # | 0001551306 |
| CUSIP | 74340E103 |
| Sector | Life Sciences - Services-Misc Health & Allied Services, Nec |
| Address | 245 5th Avenue 4th Floor, New York, NY 10016 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Progyny Inc | 2016-06-29 | 14.8 M | Exemption: 506(b) · Remaining: $5,226,853 · Duration: One year or less · Revenue: Decline to Disclose |
| Auxogyn Inc | 2015-03-19 | 34.3 M | Exemption: 506(b) · Remaining: $6,675,888 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001551306] | 10-K | |
| [0001551306] | 10-Q | |
| [0001551306] | 3 | |
| [0001551306] | 4 | |
| [0001551306] | 8-K | |
| [0001551306] | D | |
| [0001551306] | SC 13D | |
| [0001551306] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Vanguard Portfolio Management LLC | Progyny Inc | [2026-04-29] | 0.0 |
| FMR LLC | Progyny Inc | [2025-08-06] | 0.0 |
| Thrivent Financial for Lutherans | Progyny Inc | [2025-04-29] | 0.0 |
| Alger Associates Inc | Progyny Inc | [2022-02-14] | 5.0 |
| Vanguard Group Inc | Progyny Inc | [2022-02-10] | 7.16 |
| BlackRock Inc | Progyny Inc | [2022-02-04] | 8.8 |
| Schlanger David J | Progyny Inc | [2021-03-02] | 6.3 |
| Alger Associates Inc | Progyny Inc | [2021-02-16] | 5.22 |
| Macquarie Group Ltd | Progyny Inc | [2021-02-12] | 6.22 |
| GlaxoSmithKline PLC | Progyny Inc | [2020-02-14] | 12.5 |
| Kleiner Perkins Caufield & Byers XIII LLC | Progyny Inc | [2020-02-13] | 21.6 |
| TPG Group Holdings SBS Advisors Inc | Progyny Inc | [2020-02-13] | 24.4 |
| Merck KGAA | Progyny Inc | [2020-02-11] | 5.1 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Clapp Geoffrey
Common Stock
|
2026-03-17 | Tax withheld | 3,275 | $17.42 | 57,051 |
|
Livingston Mark S
Common Stock
|
2026-03-04 | Tax withheld | 339 | $17.52 | 5,939 |
|
Swartz Allison
Common Stock
|
2026-03-04 | Sell | 599 | $17.54 | 10,506 |
|
Swartz Allison
Common Stock
|
2026-03-04 | Tax withheld | 339 | $17.52 | 5,939 |
|
Livingston Mark S
Common Stock
|
2026-03-03 | Tax withheld | 4,579 | $17.60 | 80,590 |
|
Swartz Allison
Common Stock
|
2026-03-03 | Sell | 500 | $17.40 | 8,700 |
|
Anevski Peter
Common Stock
|
2026-03-03 | Tax withheld | 17,611 | $17.60 | 309,954 |
|
Swartz Allison
Common Stock
|
2026-03-03 | Sell | 4,157 | $17.40 | 72,332 |
|
Swartz Allison
Common Stock
|
2026-03-03 | Tax withheld | 2,842 | $17.60 | 50,019 |
|
Livingston Mark S
Common Stock
|
2026-03-02 | Grant | 45,454 | $0.00 | |
|
Livingston Mark S
Common Stock
|
2026-03-02 | Tax withheld | 181 | $17.69 | 3,202 |
|
Clapp Geoffrey
Common Stock
|
2026-03-02 | Grant | 35,228 | $0.00 | |
|
Swartz Allison
Common Stock
|
2026-03-02 | Tax withheld | 1,551 | $17.69 | 27,437 |
|
Swartz Allison
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 41,430 | $0.00 | |
|
Cummings Melissa B
Common Stock
|
2026-03-02 | Grant | 45,454 | $0.00 | |
|
Anevski Peter
Common Stock
|
2026-03-02 | Grant | 159,091 | $0.00 | |
|
Clapp Geoffrey
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 51,373 | $0.00 | |
|
Livingston Mark S
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 66,289 | $0.00 | |
|
Swartz Allison
Common Stock
|
2026-03-02 | Grant | 28,409 | $0.00 | |
|
Anevski Peter
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 232,011 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 293 | 79,576,174 |
| 2025-12-31 | 314 | 77,572,830 |
| 2025-09-30 | 304 | 80,675,858 |
| 2025-06-30 | 304 | 76,967,733 |
| 2025-03-31 | 291 | 71,935,149 |
| 2024-12-31 | 266 | 80,630,460 |
| 2024-09-30 | 286 | 80,212,667 |
| 2024-06-30 | 327 | 87,758,851 |
| 2024-03-31 | 329 | 90,319,663 |
| 2023-12-31 | 320 | 90,189,282 |
| 2023-09-30 | 322 | 89,496,477 |
| 2023-06-30 | 312 | 87,099,463 |